Wendy W. Pang

7.4k total citations · 3 hit papers
41 papers, 4.2k citations indexed

About

Wendy W. Pang is a scholar working on Hematology, Immunology and Molecular Biology. According to data from OpenAlex, Wendy W. Pang has authored 41 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Hematology, 21 papers in Immunology and 11 papers in Molecular Biology. Recurrent topics in Wendy W. Pang's work include Acute Myeloid Leukemia Research (19 papers), Hematopoietic Stem Cell Transplantation (16 papers) and Immune Cell Function and Interaction (7 papers). Wendy W. Pang is often cited by papers focused on Acute Myeloid Leukemia Research (19 papers), Hematopoietic Stem Cell Transplantation (16 papers) and Immune Cell Function and Interaction (7 papers). Wendy W. Pang collaborates with scholars based in United States, India and Netherlands. Wendy W. Pang's co-authors include Irving L. Weissman, Mark P. Chao, Ravindra Majeti, Siddhartha Jaiswal, Nico van Rooijen, Ash A. Alizadeh, Kenneth D. Gibbs, Christopher Y. Park, Stanley L. Schrier and Catriona Jamieson and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Nature Communications.

In The Last Decade

Wendy W. Pang

38 papers receiving 4.2k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

CD47 Is an Adverse Prognostic Factor and Therapeutic Antibody Target on Human Acute Myeloid Leukemia Stem Cells

2009 1.3k citations Ravindra Majeti, Mark P. Chao et al. Cell profile →
CD47 Is Upregulated on Circulating Hematopoietic Stem Cells and Leukemia Cells to Avoid Phagocytosis

2009 1.2k citations Siddhartha Jaiswal, Catriona Jamieson et al. Cell profile →
Human bone marrow hematopoietic stem cells are increased in frequency and myeloid-biased with age

2011 671 citations Wendy W. Pang, Derrick J. Rossi et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Wendy W. Pang United States	13	2.4k	1.4k	1.1k	1.0k	629	41	4.2k
Kay Klapproth Germany	13	2.3k 1.0×	1.6k 1.2×	649 0.6×	955 0.9×	242 0.4×	14	4.5k
Michael P. Rettig United States	27	1.1k 0.5×	977 0.7×	1.8k 1.5×	1.4k 1.3×	454 0.7×	122	3.5k
Yohei Morita Japan	32	1.4k 0.6×	2.2k 1.6×	1.9k 1.7×	716 0.7×	485 0.8×	57	4.4k
Hanno Hock United States	25	1.5k 0.6×	2.1k 1.6×	1.0k 0.9×	1.0k 1.0×	347 0.6×	52	4.2k
Robert A.J. Oostendorp Germany	35	1.1k 0.4×	1.6k 1.2×	1.2k 1.1×	664 0.6×	191 0.3×	109	3.8k
Hideo Ema Japan	34	2.1k 0.9×	2.5k 1.8×	3.2k 2.8×	840 0.8×	480 0.8×	78	5.8k
Masako Ohmura Japan	18	774 0.3×	1.8k 1.3×	1.3k 1.1×	795 0.8×	400 0.6×	29	3.8k
Damien Reynaud United States	15	1.2k 0.5×	1.3k 0.9×	1.3k 1.1×	491 0.5×	201 0.3×	27	3.0k
Fawzia Louache France	37	1.3k 0.5×	1.0k 0.8×	1.6k 1.4×	827 0.8×	198 0.3×	92	3.8k
Hayley S. Ramshaw Australia	28	1.1k 0.5×	1.1k 0.8×	950 0.8×	752 0.7×	262 0.4×	54	2.8k

Countries citing papers authored by Wendy W. Pang

Since Specialization

Citations

This map shows the geographic impact of Wendy W. Pang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wendy W. Pang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wendy W. Pang more than expected).

Fields of papers citing papers by Wendy W. Pang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wendy W. Pang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wendy W. Pang. The network helps show where Wendy W. Pang may publish in the future.

Co-authorship network of co-authors of Wendy W. Pang

This figure shows the co-authorship network connecting the top 25 collaborators of Wendy W. Pang. A scholar is included among the top collaborators of Wendy W. Pang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wendy W. Pang. Wendy W. Pang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Casale, Thomas B., Edwin W. Tucker, Jinwei Yuan, et al.. (2025). Initial results from BEACON, a phase 1b/2a dose escalation study of the anti-c-Kit briquilimab antibody in adults with chronic spontaneous urticaria (CSU). Journal of Allergy and Clinical Immunology. 155(2). AB435–AB435. 1 indexed citations

Kwon, Hye‐Sook, Song Eun Lee, Amy Sharma, et al.. (2025). Human KIT Antibody Briquilimab Diminishes Anaphylactic Responses in Mice Expressing Chimeric Human‐Mouse KIT. Allergy.

Lee, Song Eun, et al.. (2025). Briquilimab Potently Inhibits Stem Cell Factor (SCF)/c-Kit Signaling and Induces Mast Cell Apoptosis. Journal of Allergy and Clinical Immunology. 155(2). AB173–AB173. 1 indexed citations

Lee, Song Eun, Ajay Sharma, Ruiqi Huang, et al.. (2025). Anti-KIT antibody, briquilimab, induces mast cell apoptosis and depletion in nonhuman primates. Journal of Allergy and Clinical Immunology. 156(5). 1328–1340. 1 indexed citations

Chang, Charles, et al.. (2024). Amelioration Of Mrgprb2-Mediated Anaphylactoid Drug Reactions With Briquilimab, An Anti-CD117 Antibody, Through Mast Cell Depletion In Mice Expressing Chimeric Human And Mouse CD117. Journal of Allergy and Clinical Immunology. 153(2). AB241–AB241. 1 indexed citations

Hsieh, Matthew M., P Pollack, Elizabeth Harvey, et al.. (2024). Adding CD117 Antibody to Alemtuzumab, Low Dose Total Body Irradiation (TBI), and Sirolimus for Matched Related Donor (MRD) Hematopoietic Cell Transplant (HCT) in Sickle Cell Disease (SCD): Initial Results. Blood. 144(Supplement 1). 1141–1141.

Long-Boyle, Janel, et al.. (2024). Pharmacokinetics of Briquilimab as a Conditioning Agent for Hematopoietic Stem Cell Transplantation in Patients With Severe Combined Immunodeficiency, Myelodysplastic Syndrome, or Acute Myeloid Leukemia. Transplantation and Cellular Therapy. 30(9). 923.e1–923.e9. 1 indexed citations

Artz, Andrew, Catherine J. Lee, Ankur Varma, et al.. (2023). Final Results from Phase 1 Study of Briquilimab, an Anti-CD117 Monoclonal Antibody, in Combination with Low Dose Irradiation and Fludarabine Conditioning, Shows Durable Remissions in Older Adults with Acute Myeloid Leukemia in Complete Remission and Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Cell Transplantation. Blood. 142(Supplement 1). 470–470. 5 indexed citations

Muffly, Lori, Catherine J. Lee, Ankur Varma, et al.. (2022). Preliminary Data from a Phase 1 Study of JSP191, an Anti-CD117 Monoclonal Antibody, in Combination with Low Dose Irradiation and Fludarabine Conditioning Is Well-Tolerated, Facilitates Chimerism and Clearance of Minimal Residual Disease in Older Adults with MDS/AML Undergoing Allogeneic HCT. Transplantation and Cellular Therapy. 28(3). S476–S478. 2 indexed citations

10.

Pang, Wendy W., Agnieszka Czechowicz, Aaron C. Logan, et al.. (2019). Anti-CD117 antibody depletes normal and myelodysplastic syndrome human hematopoietic stem cells in xenografted mice. Blood. 133(19). 2069–2078. 43 indexed citations

11.

Czechowicz, Agnieszka, Rahul Palchaudhuri, Yu Hu, et al.. (2019). Selective hematopoietic stem cell ablation using CD117-antibody-drug-conjugates enables safe and effective transplantation with immunity preservation. Nature Communications. 10(1). 617–617. 132 indexed citations

12.

Pang, Wendy W., Stanley L. Schrier, & Irving L. Weissman. (2016). Age-associated changes in human hematopoietic stem cells. Seminars in Hematology. 54(1). 39–42. 83 indexed citations

13.

Rolls, Asya, Wendy W. Pang, Ingrid Ibarra, et al.. (2015). Sleep disruption impairs haematopoietic stem cell transplantation in mice. Nature Communications. 6(1). 8516–8516. 33 indexed citations

14.

Lavender, Kerry J., Wendy W. Pang, Ronald J. Messer, et al.. (2013). BLT-humanized C57BL/6 Rag2−/−γc−/−CD47−/− mice are resistant to GVHD and develop B- and T-cell immunity to HIV infection. Blood. 122(25). 4013–4020. 99 indexed citations

15.

Czechowicz, Agnieszka, et al.. (2011). Targeted Clearance of Human Hematopoietic Stem Cell Niches Via Inhibition of SCF Signaling Using Monoclonal Antibody SR-1. Biology of Blood and Marrow Transplantation. 17(2). S187–S188. 4 indexed citations

16.

Jaiswal, Siddhartha, Catriona Jamieson, Wendy W. Pang, et al.. (2009). CD47 Is Upregulated on Circulating Hematopoietic Stem Cells and Leukemia Cells to Avoid Phagocytosis. Cell. 138(2). 271–285. 1210 indexed citations breakdown →

17.

Cao, Thai M., Laura C. Lazzeroni, Schickwann Tsai, et al.. (2009). Identification of a Major Susceptibility Locus for Lethal Graft-versus-Host Disease in MHC-Matched Mice. The Journal of Immunology. 183(1). 462–469. 2 indexed citations

18.

Raval, Aparna, Christopher Y. Park, Wendy W. Pang, et al.. (2009). NPM1 Haploinsufficiency Results in Increased Numbers of Hematopoietic Stem Cells and Progenitor Cells.. Blood. 114(22). 738–738. 2 indexed citations

19.

Majeti, Ravindra, Mark P. Chao, Ash A. Alizadeh, et al.. (2009). CD47 Is an Adverse Prognostic Factor and Therapeutic Antibody Target on Human Acute Myeloid Leukemia Stem Cells. Cell. 138(2). 286–299. 1340 indexed citations breakdown →

20.

Chua, Katrin F., Raúl Mostoslavsky, David B. Lombard, et al.. (2005). Mammalian SIRT1 limits replicative life span in response to chronic genotoxic stress. Cell Metabolism. 2(1). 67–76. 203 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact